Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sims

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
Scientific Reports|May 24, 2019
A systematic study towards evolutionary and epidemiological dynamics of currently predominant H5 highly pathogenic avian influenza viruses in VietnamLam Thanh Nguyen, Simon M Firestone, Mark A Stevenson, et al.
Circulation|September 25, 2025
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Dhruv S Kazi, Abdul R Abdullah, et al.
Critical Care Medicine|June 28, 2023
Analysis of Protein Biomarkers From Hospitalized COVID-19 Patients Reveals Severity-Specific Signatures and Two Distinct Latent Profiles With Differential Responses to CorticosteroidsPhilip A Verhoef, Alexandra B Spicer, Carlos Lopez-Espina, et al.
Gastroenterology|November 5, 2013
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infectionGregory T Everson, Karen D Sims, Maribel Rodriguez-Torres, et al.
Antiviral Research|September 26, 2024
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virusAngela M Lam, Nagraj Mani, Andrzej Ardzinski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Physiological Genomics|March 12, 2025
From castaways to discoveries: unveiling treasures in skin RNAseq using a novel multidimensional data processing workflow including infection-host dynamicsDisha Bhargava, Alec Labadie, Rebecca L Hanson-Rios-Stutz, et al.
Genome Announcements|January 24, 2015
Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface EnvironmentC Hwang, A Copeland, S Lucas, et al.
Microorganisms|September 28, 2024
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential ProteinsJeremy W Prokop, Sheryl Alberta, Martin Witteveen-Lane, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Scientific Reports|May 24, 2019
A systematic study towards evolutionary and epidemiological dynamics of currently predominant H5 highly pathogenic avian influenza viruses in VietnamLam Thanh Nguyen, Simon M Firestone, Mark A Stevenson, et al.
Circulation|September 25, 2025
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Dhruv S Kazi, Abdul R Abdullah, et al.
Critical Care Medicine|June 28, 2023
Analysis of Protein Biomarkers From Hospitalized COVID-19 Patients Reveals Severity-Specific Signatures and Two Distinct Latent Profiles With Differential Responses to CorticosteroidsPhilip A Verhoef, Alexandra B Spicer, Carlos Lopez-Espina, et al.
Gastroenterology|November 5, 2013
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infectionGregory T Everson, Karen D Sims, Maribel Rodriguez-Torres, et al.
Antiviral Research|September 26, 2024
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virusAngela M Lam, Nagraj Mani, Andrzej Ardzinski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Physiological Genomics|March 12, 2025
From castaways to discoveries: unveiling treasures in skin RNAseq using a novel multidimensional data processing workflow including infection-host dynamicsDisha Bhargava, Alec Labadie, Rebecca L Hanson-Rios-Stutz, et al.
Genome Announcements|January 24, 2015
Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface EnvironmentC Hwang, A Copeland, S Lucas, et al.
Microorganisms|September 28, 2024
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential ProteinsJeremy W Prokop, Sheryl Alberta, Martin Witteveen-Lane, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Pageof 21